AI Verdict
PTRN has stronger fundamentals based on our AI analysis.
PTRN vs PTIXW Fundamental Comparison
| Metric | PTRN | PTIXW |
|---|---|---|
| Revenue | $2.5B | $0.0 |
| Net Income | $16.2M | $-3.7M |
| Net Margin | 0.6% | N/A |
| ROE | 2.8% | N/A |
| ROA | 1.7% | -83.9% |
| Current Ratio | 2.34x | 0.34x |
| Debt/Equity | 0.00x | N/A |
| EPS | $-1.36 | $-1.50 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PTRN vs PTIXW: Frequently Asked Questions
Is PTRN or PTIXW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), PTRN has stronger fundamentals. PTRN is rated HOLD (62% confidence) while PTIXW is rated STRONG SELL (88% confidence). This is not investment advice.
How does PTRN compare to PTIXW fundamentally?
Pattern Group Inc. has ROE of 2.8% vs Protagenic Therapeutics, Inc.new's N/A. Net margins are 0.6% vs N/A respectively.
Which stock pays higher dividends, PTRN or PTIXW?
PTRN has a dividend yield of N/A or no dividend while PTIXW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PTRN or PTIXW for long term?
For long-term investing, consider that PTRN has HOLD rating with 62% confidence, while PTIXW has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PTRN vs PTIXW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PTRN vs PTIXW, the AI consensus favors PTRN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.